A citation-based method for searching scientific literature

Sue Kinnamon, Thomas Finger. Handb Exp Pharmacol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.
David Richards, Joel R Gever, Anthony P Ford, Samuel J Fountain. Br J Pharmacol 2019
40
100


Pharmacology of P2X channels.
Joel R Gever, Debra A Cockayne, Michael P Dillon, Geoffrey Burnstock, Anthony P D W Ford. Pflugers Arch 2006
246
100

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough.
David R Muccino, Alyn H Morice, Surinder S Birring, Peter V Dicpinigaitis, Ian D Pavord, Christopher Assaid, Huub Jan Kleijn, Azher Hussain, Carmen La Rosa, Lorcan McGarvey,[...]. ERJ Open Res 2020
28
100

The role of ATP in cough hypersensitivity syndrome: new targets for treatment.
Mengru Zhang, Shengyuan Wang, Li Yu, Xianghuai Xu, Zhongmin Qiu. J Thorac Dis 2020
5
100

Purine and pyrimidine receptors.
G Burnstock. Cell Mol Life Sci 2007
688
100

Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report.
Peter Gibson, Gang Wang, Lorcan McGarvey, Anne E Vertigan, Kenneth W Altman, Surinder S Birring. Chest 2016
136
100

Purinergic Signalling: Therapeutic Developments.
Geoffrey Burnstock. Front Pharmacol 2017
221
100

Inhibition of P2X7R in the amygdala ameliorates symptoms of neuropathic pain after spared nerve injury in rats.
Xiaoling Hu, Yiming Liu, Junting Wu, Yu Liu, Wenjie Liu, Ji Chen, Fengrui Yang. Brain Behav Immun 2020
13
100

Etiology and treatment of cough in idiopathic pulmonary fibrosis.
Christine L Vigeland, Andrew H Hughes, Maureen R Horton. Respir Med 2017
18
100

Potential for developing purinergic drugs for gastrointestinal diseases.
Fernando Ochoa-Cortes, Andromeda Liñán-Rico, Kenneth A Jacobson, Fievos L Christofi. Inflamm Bowel Dis 2014
43
100

Allergic sensitization increases the amount of extracellular ATP hydrolyzed by guinea pig leukocytes.
Jaime Chávez, Mario H Vargas, Jesús Martínez-Zúñiga, Ramcés Falfán-Valencia, Enrique Ambrocio-Ortiz, Verónica Carbajal, Rosa Sandoval-Roldán. Purinergic Signal 2019
5
100

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.
Saifudin Khalid, Robert Murdoch, Amy Newlands, Kevin Smart, Angela Kelsall, Kimberley Holt, Rachel Dockry, Ashley Woodcock, Jaclyn A Smith. J Allergy Clin Immunol 2014
109
100

Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough.
Mengru Zhang, Yiqing Zhu, Ran Dong, Zhongmin Qiu. J Thorac Dis 2020
2
100

Recommended tool compounds and drugs for blocking P2X and P2Y receptors.
Christa E Müller, Vigneshwaran Namasivayam. Purinergic Signal 2021
9
100


P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling.
Sylvia O Suadicani, Celia F Brosnan, Eliana Scemes. J Neurosci 2006
410
100

Cough Hypersensitivity Syndrome: A Few More Steps Forward.
Woo Jung Song, Alyn H Morice. Allergy Asthma Immunol Res 2017
67
100

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.
Alyn H Morice, Eva Millqvist, Kristina Bieksiene, Surinder S Birring, Peter Dicpinigaitis, Christian Domingo Ribas, Michele Hilton Boon, Ahmad Kantar, Kefang Lai, Lorcan McGarvey,[...]. Eur Respir J 2020
202
100

The discovery and development of gefapixant.
Anthony P Ford, Michael P Dillon, Michael M Kitt, Joel R Gever. Auton Neurosci 2021
8
100

Purine and pyrimidine (P2) receptors as drug targets.
Kenneth A Jacobson, Michael F Jarvis, Michael Williams. J Med Chem 2002
226
100

Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials.
Ahmed Abu-Zaid, Aseel Khalid Aljaili, Amnah Althaqib, Fatima Adem, Doaa Ali Alhalal, Amena Faiq Almubarak, Saud Musaab Aldughaither, Sarah Ali Alghabban, Ghaidaa Alfaraj, Ahmed Taher Masoud,[...]. Ann Thorac Med 2021
6
100


Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Kenneth A Jacobson, Adriaan P IJzerman, Christa E Müller. Biochem Pharmacol 2021
20
100

Purinergic nerves.
G Burnstock. Pharmacol Rev 1972
100

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.
Jaclyn A Smith, Michael M Kitt, Alyn H Morice, Surinder S Birring, Lorcan P McGarvey, Mandel R Sher, Yu-Ping Li, Wen-Chi Wu, Zhi Jin Xu, David R Muccino,[...]. Lancet Respir Med 2020
105
100

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
Lorcan P McGarvey, Surinder S Birring, Alyn H Morice, Peter V Dicpinigaitis, Ian D Pavord, Jonathan Schelfhout, Allison Martin Nguyen, Qing Li, Anjela Tzontcheva, Beata Iskold,[...]. Lancet 2022
25
100


Extracellular adenosine triphosphate and chronic obstructive pulmonary disease.
Marek Lommatzsch, Sanja Cicko, Tobias Müller, Monica Lucattelli, Kai Bratke, Paul Stoll, Melanie Grimm, Thorsten Dürk, Gernot Zissel, Davide Ferrari,[...]. Am J Respir Crit Care Med 2010
143
100

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough.
Valerie J Ludbrook, Kate E Hanrott, James L Kreindler, Joanna E Marks-Konczalik, Nick P Bird, Debbie A Hewens, Misba Beerahee, David J Behm, Alyn Morice, Lorcan McGarvey,[...]. ERJ Open Res 2021
4
100

Gefapixant in two randomised dose-escalation studies in chronic cough.
Jaclyn A Smith, Michael M Kitt, Peter Butera, Steven A Smith, Yuping Li, Zhi Jin Xu, Kimberley Holt, Shilpi Sen, Mandel R Sher, Anthony P Ford. Eur Respir J 2020
61
100

Looking ahead to novel therapies for chronic cough. Part 1 - peripheral sensory nerve targeted treatments.
Elzbieta M Grabczak, Marta Dabrowska, Surinder S Birring, Rafal Krenke. Expert Rev Respir Med 2020
3
100

Tussive challenge with ATP and AMP: does it reveal cough hypersensitivity?
Helen Elizabeth Fowles, Tim Rowland, Caroline Wright, Alyn Morice. Eur Respir J 2017
42
100

Subtypes of vagal afferent C-fibres in guinea-pig lungs.
B J Undem, B Chuaychoo, M-G Lee, D Weinreich, A C Myers, M Kollarik. J Physiol 2004
186
100

Extracellular ATP as a signaling molecule for epithelial cells.
Erik M Schwiebert, Akos Zsembery. Biochim Biophys Acta 2003
346
100


P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.
Rayid Abdulqawi, Rachel Dockry, Kimberley Holt, Gary Layton, Bruce G McCarthy, Anthony P Ford, Jaclyn A Smith. Lancet 2015
301
100


The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study.
Alyn H Morice, Michael M Kitt, Anthony P Ford, Andrew M Tershakovec, Wen-Chi Wu, Kayleigh Brindle, Rachel Thompson, Susannah Thackray-Nocera, Caroline Wright. Eur Respir J 2019
71
100

Assessment of Pharmacokinetic Interaction Between Gefapixant (MK-7264), a P2X3 Receptor Antagonist, and the OATP1B1 Drug Transporter Substrate Pitavastatin.
Jacqueline B McCrea, Azher Hussain, Bennett Ma, Graigory C Garrett, Raymond Evers, John E Laabs, S Aubrey Stoch, Marian Iwamoto. Clin Pharmacol Drug Dev 2022
4
100

Treatment of chronic neuropathic pain: purine receptor modulation.
Kenneth A Jacobson, Luigino Antonio Giancotti, Filomena Lauro, Fatma Mufti, Daniela Salvemini. Pain 2020
35
100

XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.
Maria G Belvisi, Mark A Birrell, Michael A Wortley, Sarah A Maher, Imran Satia, Huda Badri, Kimberley Holt, Patrick Round, Lorcan McGarvey, John Ford,[...]. Am J Respir Crit Care Med 2017
80
100

Transcutaneous Electrical Nerve Stimulation as a Treatment for Neuropathic Cough: A Tolerability and Feasibility Study.
Alexandra Michalowski, Adam Haines, Naum Shaparin, Karina Gritsenko, Alan D Kaye, Elyse M Cornett, Michael Z Lerner. Neurol Ther 2021
2
100

Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs.
Brendan J Canning, Stuart B Mazzone, Sonya N Meeker, Nanako Mori, Sandra M Reynolds, Bradley J Undem. J Physiol 2004
305
100

Opiate therapy in chronic cough.
Alyn H Morice, Madhav S Menon, Siobhan A Mulrennan, Caroline F Everett, Caroline Wright, Jennifer Jackson, Rachel Thompson. Am J Respir Crit Care Med 2007
183
100

Opposing effects of bronchopulmonary C-fiber subtypes on cough in guinea pigs.
Yang-Ling Chou, Nanako Mori, Brendan J Canning. Am J Physiol Regul Integr Comp Physiol 2018
30
100

Purinergic signaling in the airways.
Geoffrey Burnstock, Inge Brouns, Dirk Adriaensen, Jean-Pierre Timmermans. Pharmacol Rev 2012
114
100


Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells.
Marco Idzko, Hamida Hammad, Menno van Nimwegen, Mirjam Kool, Monique A M Willart, Femke Muskens, Henk C Hoogsteden, Werner Luttmann, Davide Ferrari, Francesco Di Virgilio,[...]. Nat Med 2007
457
100

Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit.
Xiaochun Bian, Jianhua Ren, Matthew DeVries, Birthe Schnegelsberg, Debra A Cockayne, Anthony P D W Ford, James J Galligan. J Physiol 2003
91
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.